Biosyent annonce le lancement du nouveau FeraMAX(MD) Pd Thérapeutique 150
05 nov. 2020 08h00 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, 05 nov. 2020 (GLOBE NEWSWIRE) -- BioSyent Inc. (« BioSyent », « la Société », Bourse de croissance : RX) a le plaisir d’annoncer le lancement de FeraMAXMD Pd Thérapeutique 150,...
BioSyent Named to the Growth List Ranking of Canada’s Fastest-Growing Companies for Eighth Consecutive Year
15 oct. 2020 09h00 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, Oct. 15, 2020 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it has been included in the 32nd annual Growth List, the definitive...
BioSyent Annonce L'Introduction du Nouveau FeraMAX® Pd
05 oct. 2020 08h00 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, 05 oct. 2020 (GLOBE NEWSWIRE) -- BioSyent Inc. (« BioSyent », « la Société », Bourse de croissance : RX) a le plaisir d’annoncer l’introduction de FeraMAX® Pd, une nouvelle...
BioSyent Announces Introduction of New FeraMAX® Pd
05 oct. 2020 08h00 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, Oct. 05, 2020 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce the introduction of FeraMAX® Pd, a new oral iron supplement...
BioSyent Signs Exclusive Agreement for New Women’s Health Product
01 oct. 2020 09h25 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, Oct. 01, 2020 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that its subsidiary, BioSyent Pharma Inc., has signed an exclusive License...
BioSyent Releases Q2 and H1 2020 Results
26 août 2020 07h30 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, Aug. 26, 2020 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today a summary of its financial results for the three and six months ended June 30,...
BioSyent to Present at the LD 500 Virtual Conference
24 août 2020 16h30 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, Aug. 24, 2020 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) today announced that it will be presenting at the LD 500 investor conference on...
BioSyent Schedules Q2 and H1 2020 Earnings Release for August 26, 2020
17 août 2020 08h30 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, Aug. 17, 2020 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three and six months ended June 30,...
BioSyent Announces the Availability of Tibella® (tibolone) in Canada
29 juil. 2020 16h01 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, July 29, 2020 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) today announced the Canadian launch and product availability of Tibella® (tibolone)...
BioSyent Releases Results for Q1 2020
28 mai 2020 08h00 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, May 28, 2020 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today a summary of its financial results for the three months ended March 31, 2020. Key...